We are live on ! Find out more
LAB icon

Standard BioTools
LAB

68 hedge funds and large institutions have $54.2M invested in Standard BioTools in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $42.5M → $54.2M (+$11.7M)

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

9.5% more ownership

Funds ownership: 49.12% → 58.62% (+9.5%)

5% more funds holding

Funds holding: 65 → 68 (+3)

18% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 22

65% less call options, than puts

Call options by funds: $37K | Put options by funds: $107K

Holders
68
Holders Change
+3
Holders Change %
+4.62%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
18
Reduced
22
Closed
11
Calls
$37K
Puts
$107K
Net Calls
-$70K
Net Calls Change
-$18K

Top Buyers

1
HBWM
Hollow Brook Wealth Management
New York
+$861K
2
HighTower Advisors
HighTower Advisors
Illinois
+$257K
3
Morgan Stanley
Morgan Stanley
New York
+$209K
4
JCP
Jennifer C. Price
+$146K
5
BCM
Bridgeway Capital Management
Texas
+$61.6K

Top Sellers

1
BlackRock
BlackRock
New York
-$712K
2
Primecap Management
Primecap Management
California
-$382K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$293K
4
PVI
Pura Vida Investments
New York
-$278K
5
E
Ergoteles
New York
-$220K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$4K -$7.51K -6,098 -60%
PPC
52
Park Place Capital
Alabama
$3K +$3.46K +2,808 New
BA
53
Bellwether Advisors
Nebraska
$2.36K – – –
BAM
54
Belpointe Asset Management
Nevada
$2.34K +$2.46K +2,000 New
SSB
55
Sandy Spring Bank
Maryland
$1.17K – – –
Wells Fargo
56
Wells Fargo
California
$1.01K +$20 +16 +2%
JP Morgan Chase
57
JP Morgan Chase
New York
$1K – – –
ASN
58
Advisory Services Network
Georgia
$585 +$616 +500 New
Bank of America
59
Bank of America
North Carolina
$508 +$517 +420 +3,000%
RFS
60
Retirement Financial Solutions
Tennessee
$373 +$393 +319 New
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$336 +$28 +23 +9%
Dimensional Fund Advisors
62
Dimensional Fund Advisors
Texas
$176 -$293K -238,348 -61%
HGWM
63
Harvest Group Wealth Management
Massachusetts
$170 – – –
RP
64
Repertoire Partners
New York
$117 – – –
MCC
65
Money Concepts Capital
Florida
$117 +$123 +100 New
Citigroup
66
Citigroup
New York
$71 -$6 -5 -8%
PVI
67
Pura Vida Investments
New York
– -$278K -253,132 Closed
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
– -$68K -61,366 Closed
Allspring Global Investments
69
Allspring Global Investments
North Carolina
– -$36K -33,462 Closed
LP
70
LMR Partners
United Kingdom
– -$30K -27,176 Closed
Charles Schwab
71
Charles Schwab
California
– -$30K -27,127 Closed
Principal Financial Group
72
Principal Financial Group
Iowa
– -$26K -24,088 Closed
GF
73
Gabelli Funds
New York
– -$23K -20,618 Closed
SFI
74
Susquehanna Fundamental Investments
Pennsylvania
– -$20K -18,141 Closed
AGM
75
Alpine Global Management
New York
– -$15K -13,475 Closed
1 2
3
4

LAB Hedge Fund Activity: Q4 2022 in Review

68 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2022, worth a combined $54.2M — up 28% from $42.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new LAB positions and 11 closed out — a net gain of 3 holders — while 18 added to existing stakes and 22 trimmed.

The largest buyer was Hollow Brook Wealth Management, opening a new position worth an estimated $861K. The largest seller was BlackRock, cutting an estimated $712K.

  • 68 institutional investors held Standard BioTools (LAB) as of Q4 2022, up from 65 in Q3 2022.
  • Funds reported $54.2M of Standard BioTools stock for Q4 2022, up 28% quarter-over-quarter.
  • 14 funds opened new Standard BioTools positions in Q4 2022 and 11 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q4 2022 was Hollow Brook Wealth Management, an estimated $861K added.
  • The largest Standard BioTools seller in Q4 2022 was BlackRock, an estimated $712K sold.

Based on aggregated 13F filings for Q4 2022.